Bath & Body Works shares have extended their decline, reaching a fresh 52-week low during Wednesday’s trading session. The stock closed at $24.82 after declining 4.9% for the day, signaling continued downward momentum that has investors concerned about when the slide might stabilize.
Financial Performance Metrics
While the company met expectations in its most recent quarterly report with earnings per share of $0.37 and revenue of $1.55 billion, deeper examination reveals underlying challenges. Revenue showed a year-over-year contraction of 0.8%, indicating potential headwinds for the business. The stock’s current trading position below key technical indicators—$27.35 for the 50-day moving average and $29.04 for the 200-day moving average—further underscores the negative trend. Even with a price-to-earnings ratio of 7.37 and market capitalization of $5.12 billion, investors remain cautious.
Analyst Downgrades and Price Target Cuts
Market analysts have responded to the deteriorating situation with significant adjustments to their assessments:
Should investors sell immediately? Or is it worth buying Bath & Body Works?
- Jefferies Financial Group reduced its price target from $32.00 to $28.50 back in October
- Wells Fargo & Company implemented a more substantial cut, lowering their target from $44.00 to $33.00
- Wall Street Zen downgraded its rating from “Buy” to “Hold”
Analysts point to inconsistent product launches and mounting margin pressure as primary factors behind these revised outlooks.
Institutional Stance Amid Retail Exodus
As retail investors reduce their exposure, Victory Capital Management maintains its substantial position in the company. The investment firm holds 8.4 million shares, representing 4.08% of outstanding equity, and retains both voting and disposal rights. This institutional commitment raises questions about whether such support can potentially counterbalance the current negative momentum.
Market Context and Recent Performance
The broader consumer goods sector appears to be facing increasing headwinds, contributing to the challenging environment for Bath & Body Works. Recent trading patterns show the stock has declined in six of the last ten sessions, resulting in a cumulative loss of 8.0% over that period. With the stock establishing a new 52-week low at $24.84 during Wednesday’s session, market participants are watching closely for any signs of stabilization or reversal in the current trend.
Ad
Bath & Body Works Stock: Buy or Sell?! New Bath & Body Works Analysis from November 1 delivers the answer:
The latest Bath & Body Works figures speak for themselves: Urgent action needed for Bath & Body Works investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 1.
Bath & Body Works: Buy or sell? Read more here...









